Among postmenopausal women with a history of cancer, taking more daily steps and engaging in moderate-to-vigorous physical activity were both associated with a significantly reduced risk...
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a Phase 2 clinical trial....
There has been a “shocking” decline in testing for cancer in women across the globe, a new report has revealed. Only 10 per cent of women...
Telephone-delivered acceptance and commitment therapy (ACT) is beneficial for reducing fatigue’s interference with functioning and improves the quality of life for survivors of metastatic breast cancer,...
A new, at-home cervical cancer screening test will be launched with the backing of US$10m in funding. The Teal Wand, a at-home screening device and telehealth...
A new US collaboration will see the launch of a mobile mammography unit that aims to address gaps in access to care. Part of a larger...
An integrated polygenic risk score (iPRS) for personalised breast cancer risk assessment has been launched which reports five-year and lifetime breast cancer risk, offers individuals who...
A new approach to treating ovarian cancer has been discovered that, in preclinical laboratory testing, shrinks tumours and improves survival rates while simultaneously making tumours more...
As Breast Cancer Awareness Month begins, medtech company Paxman is raising awareness of a critical and often overlooked side effect faced by many cancer patients: the...
Girls with mental illness or neurodevelopmental conditions are less likely than their peers to be vaccinated with the HPV vaccine that protects against future cervical cancer. ...
